SCHEMBL13015669

SCHEMBL13015669

Oc1ccc2cc(-c3c4ccccc4c(-c4ccccc4)c4ccccc34)ccc2c1

nearest known ligand 0.69

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ESR2 Q92731 12/20 0.69
▸ ESR1 P03372 11/20 0.69
▸ CYP1A2 P05177 4/20 0.58
▸ HSD17B1 P14061 4/20 0.58
▸ HSD17B2 P37059 4/20 0.58
▸ CYP3A4 P08684 3/20 0.58
▸ CYP2D6 P10635 3/20 0.58
▸ CYP2C9 P11712 3/20 0.58
▸ CYP2B6 P20813 3/20 0.58
▸ CYP2C19 P33261 3/20 0.58
▸ ABL1 P00519 1/20 0.50
▸ ABCB1 P08183 1/20 0.50
▸ BCR P11274 1/20 0.50
▸ CYP19A1 P11511 1/20 0.49
▸ CYP11B1 P15538 1/20 0.49
▸ CYP11B2 P19099 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14506091 0.91 CYP1A2 (0.65) ESR2ESR1CYP1A2HSD17B1HSD17B2
SCHEMBL12571896 0.87 ESR2 (0.68) ESR2ESR1CYP1A2HSD17B1HSD17B2
SCHEMBL27845544 0.85 ALOX5 (0.62) ESR2ESR1CYP1A2HSD17B1HSD17B2
SCHEMBL13977065 0.84 ESR2 (0.53) ESR2ESR1CYP1A2HSD17B1HSD17B2
SCHEMBL14506092 0.84 ESR2 (0.59) ESR2ESR1CYP1A2HSD17B1HSD17B2
SCHEMBL5502280 0.84 ESR1 (0.53) ESR2ESR1CYP1A2HSD17B1HSD17B2
SCHEMBL15366592 0.84 ESR1 (0.55) ESR2ESR1CYP1A2HSD17B1HSD17B2
SCHEMBL30730877 0.84 ESR1 (0.53) ESR2ESR1CYP1A2HSD17B1HSD17B2
SCHEMBL11977707 0.84 ESR2 (0.60) ESR2ESR1CYP1A2HSD17B1HSD17B2
SCHEMBL27864699 0.84 HSD17B1 (0.76) ESR2ESR1CYP1A2HSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023239193-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME 주식회사 엘지화학 2023-12-14 — — WO disclosed
US-20170033293-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME JNC CORPORATION (JP) 2017-02-02 — — US disclosed
US-20170033293-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME JNC CORPORATION (JP) 2017-02-02 — — US disclosed
WO-2015141608-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME JNC株式会社 2015-09-24 — — WO disclosed
CN-102414179-A Electron transport material and organic electroluminescent element using same JNC CORP 2012-04-11 — — CN disclosed
WO-2010137678-A1 ELECTRON TRANSPORTING MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME チッソ株式会社 (JP) 2010-12-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170033293-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME SLC26A3, SLC9A1, HVCN1 ESR2 358/4885ESR1 284/4885CYP1A2 965/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback